東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Utilizing Chemoproteomics to Discove...

Berdan, Charles A.

FindBook

Google Book

Amazon

博客來

Utilizing Chemoproteomics to Discover Novel Druggable Hotspots Targeted by Natural Products.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Utilizing Chemoproteomics to Discover Novel Druggable Hotspots Targeted by Natural Products./
作者:	Berdan, Charles A.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2019,
面頁冊數:	148 p.
附註:	Source: Dissertations Abstracts International, Volume: 81-03, Section: B.
Contained By:	Dissertations Abstracts International81-03B.
標題:	Biochemistry. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13861428
ISBN:	9781085781145

Utilizing Chemoproteomics to Discover Novel Druggable Hotspots Targeted by Natural Products.
Berdan, Charles A.

Utilizing Chemoproteomics to Discover Novel Druggable Hotspots Targeted by Natural Products. - Ann Arbor : ProQuest Dissertations & Theses, 2019 - 148 p.

Source: Dissertations Abstracts International, Volume: 81-03, Section: B.

Thesis (Ph.D.)--University of California, Berkeley, 2019.

This item must not be sold to any third party vendors.

It is estimated that over 1.7 million people will be diagnosed with cancer and 600,000 people will die from cancer in 2019. The need for new therapeutics against cancer is therefore imperative. Natural product based drug discovery has provided a multitude of effective answers to many diseases, however difficulties in synthesizing natural products, isolating them, and deciphering their mechanism of action can limit translating more natural products into the clinic. Coupling natural product based drug discovery with chemical genetics and with powerful chemoproteomic strategies can allow for new questions to be asked and potentially new therapeutics to be developed even from formerly well-characterized molecules.Parthenolide, a natural product from the feverfew plant and member of the large family of sesquiterpene lactones, exerts multiple biological and therapeutic activities including anti-inflammatory and anti-cancer effects. Herein, we further study parthenolide mechanism of action using activity-based protein profiling (ABPP)-based chemoproteomic platforms to map additional covalent targets engaged by parthenolide in human breast cancer cells. We find that parthenolide, as well as other related exocyclic methylene lactone-containing sesquiterpenes, covalently modify cysteine 427 (C427) of focal adhesion kinase 1 (FAK1) leading to impairment of FAK1-dependent signaling pathways and breast cancer cell proliferation, survival, and motility. These studies reveal a novel functional target exploited by members of a large family of anticancer natural products.

ISBN: 9781085781145Subjects--Topical Terms:

518028
Biochemistry.
Subjects--Index Terms:

Drug discovery

Utilizing Chemoproteomics to Discover Novel Druggable Hotspots Targeted by Natural Products.
LDR:02775nmm a2200361 4500 001 2272475
005 20201105110103.5
008 220629s2019 ||||||||||||||||| ||eng d
020 $a 9781085781145
035 $a (MiAaPQ)AAI13861428
035 $a AAI13861428
040 $a MiAaPQ $c MiAaPQ
100 1 $a Berdan, Charles A. $3 3549911
245 1 0 $a Utilizing Chemoproteomics to Discover Novel Druggable Hotspots Targeted by Natural Products.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2019
300 $a 148 p.
500 $a Source: Dissertations Abstracts International, Volume: 81-03, Section: B.
500 $a Advisor: Nomura, Daniel.
502 $a Thesis (Ph.D.)--University of California, Berkeley, 2019.
506 $a This item must not be sold to any third party vendors.
506 $a This item must not be added to any third party search indexes.
520 $a It is estimated that over 1.7 million people will be diagnosed with cancer and 600,000 people will die from cancer in 2019. The need for new therapeutics against cancer is therefore imperative. Natural product based drug discovery has provided a multitude of effective answers to many diseases, however difficulties in synthesizing natural products, isolating them, and deciphering their mechanism of action can limit translating more natural products into the clinic. Coupling natural product based drug discovery with chemical genetics and with powerful chemoproteomic strategies can allow for new questions to be asked and potentially new therapeutics to be developed even from formerly well-characterized molecules.Parthenolide, a natural product from the feverfew plant and member of the large family of sesquiterpene lactones, exerts multiple biological and therapeutic activities including anti-inflammatory and anti-cancer effects. Herein, we further study parthenolide mechanism of action using activity-based protein profiling (ABPP)-based chemoproteomic platforms to map additional covalent targets engaged by parthenolide in human breast cancer cells. We find that parthenolide, as well as other related exocyclic methylene lactone-containing sesquiterpenes, covalently modify cysteine 427 (C427) of focal adhesion kinase 1 (FAK1) leading to impairment of FAK1-dependent signaling pathways and breast cancer cell proliferation, survival, and motility. These studies reveal a novel functional target exploited by members of a large family of anticancer natural products.
590 $a School code: 0028.
650 4 $a Biochemistry. $3 518028
650 4 $a Biology. $3 522710
650 4 $a Cellular biology. $3 3172791
653 $a Drug discovery
653 $a Parthenolide
653 $a Breast cancer
690 $a 0487
690 $a 0306
690 $a 0379
710 2 $a University of California, Berkeley. $b Molecular & Biochemical Nutrition. $3 2101028
773 0 $t Dissertations Abstracts International $g 81-03B.
790 $a 0028
791 $a Ph.D.
792 $a 2019
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13861428